Hana Pharm and related party drastically reduce stake in Samjin Pharmaceutical from 8.33% to 0.75%... On-market sale for simple investment purpose puts downward pressure on stock
Filer Hana Pharm and specially related person Jo Dong-hoon sold approximately 1.058 million shares of Samjin Pharmaceutical on the market, reducing their combined stake from 8.33% (previous) to 0.75% (current).
Sales occurred in multiple transactions from August 2025 to May 2026, with average selling prices ranging from 18,880 won to 25,389 won.
The purpose is stated as 'simple investment', indicating no intent to influence management.
Meanwhile, Samjin Pharmaceutical's total voting shares decreased from 13,900,000 to 13,320,000 (a reduction of 580,000 shares, about 4.17%), which may be due to treasury share cancellation, potentially boosting shareholder value.
However, the massive reduction by a major shareholder could negatively impact sentiment, and further selling should be monitored.
[AI Comprehensive Analysis]The large-scale disposal of Samjin Pharmaceutical shares by Hana Pharm and its largest shareholder reduces the likelihood of a change in control, but it is interpreted as a lack of confidence from major shareholders, adversely affecting the stock price. Although the reduction in outstanding shares is positive, the magnitude of the sell-off is substantial, raising concerns about near-term downward pressure.
KOSPI Filing Information
Filing: [Correction of Description] Report on Large Shareholding Status (Abbreviated)